Latest Articles

Publication Date
Vaginal Contraception With NuvaRing Decreases Symptoms and Uterine Features of Adenomyosis: A Prospective Evaluation.

(Abstracted from Contraception 2025:150:111016, doi:10.1016/j.contraception.2025.111016) Adenomyosis occurs when ectopic endometrial glands invade the myometrium and can cause symptoms such as an enlarged uterus, heavy menstrual bleeding, pelvic pain, infertility, and …

Published: Dec. 12, 2025, midnight
Staged Pre-Hysterectomy Uterine Artery Embolization for Symptomatic Uterine Fibroids: A Scoping Review.

We systematically examined the current literature on staged pre-hysterectomy uterine artery embolization (SUAE) for symptomatic uterine fibroids.

Published: Dec. 11, 2025, midnight
Development of an AI-based magnetic resonance imaging reading support program (AMP) for deep endometriosis diagnosis.

Diagnosis of endometriosis faces significant challenges including diagnostic delay and reliance on invasive procedures. Deep endometriosis (DE) poses additional difficulties in non-invasive diagnosis due to its subtle and complex imaging …

Published: Dec. 8, 2025, midnight
Bayer launches phase III trial testing Mirena for uterine condition with no treatments - Indian Pharma Post

Bayer launches phase III trial testing Mirena for uterine condition with no treatments Indian Pharma Post

Published: Dec. 7, 2025, 6:02 a.m.
Age-dependent variations in clinical features and operative time for endometriotic cysts.

Endometriosis with ovarian cysts is common in reproductive-age women and contributes to pain and infertility. The influence of age on clinical and surgical outcomes remains uncertain. This retrospective study analyzed …

Published: Dec. 6, 2025, midnight
Microbiota insights in endometriosis.

Endometriosis affects approximately 10% of women of reproductive age and is characterized by the presence of endometrial-like tissue outside the uterine cavity, leading to chronic pelvic pain, infertility, and a …

Published: Dec. 5, 2025, midnight
Bayer starts Phase III study with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia - Bayer

Bayer starts Phase III study with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia Bayer

Published: Dec. 2, 2025, 7:30 a.m.
Mia X Grateful to Be Uterine Cancer Survivor After Surgery Mishap - SurvivorNet

Mia X Grateful to Be Uterine Cancer Survivor After Surgery Mishap SurvivorNet

Published: Dec. 2, 2025, 2:45 a.m.
Natural bioactive compounds and herbal medicines targeting common signaling pathways in endometriosis: mechanisms and therapeutic implications.

For a very long time, herbal treatments have served as remedies for various humans and animals. Natural compounds typically have multiple pharmacological actions because they interact with various biological targets. …

Published: Dec. 2, 2025, midnight
Histomorphometric characterization of the endometrium in mules (Equus mulus): An approach to endometritis/endometrosis.

Mules (Equus mulus), as sterile hybrids between mares and donkeys, present a unique uterine morphology and physiology that remains poorly characterized. This study provides the first histomorphometric evaluation and transcriptional …

Published: Dec. 2, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!